do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline GLP 1 Agonists and DPP 4 Inhibitors Mechanism of Action Mapping the effectiveness and risks

Your provider needs to be involved from the beginning

Such brief investigations do not provide ample evidence to fully understand the ramifications of increased GH levels via ipamorelin therapy, despite the peptide's evident potency

You should contact your GP, call NHS 111, or seek urgent medical advice if you are currently using unlicensed peptides and experience any of the following: Severe or persistent nausea, vomiting, or abdominal pain Signs of infection at an injection site (redness, swelling, warmth, discharge) Unexplained changes in heart rate or palpitations Symptoms of an allergic reaction (rash, swelling, difficulty breathing) Persistent right upper quadrant pain, fever, or jaundice (which may indicate gallbladder problems) Significant unintentional weight loss or fatigue Call 999 or go to your nearest emergency department if symptoms are severe or rapidly worsening

B., Andreassen, T

Gui et al